Drug Type Enzyme |
Synonyms NTR 452, NTR452 |
Target |
Mechanism LEKTI replacements(Serine protease inhibitor Kazal-type 5 replacements) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Neutrolis, Inc.Startup |
Active Organization- |
Inactive Organization Neutrolis, Inc.Startup |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | US | Neutrolis, Inc.Startup | 29 Jul 2021 |